Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Baricitinib shows promise for treating alopecia areata with mild side effects.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

The woman's widespread skin condition did not improve despite various treatments.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Kikuchi–Fujimoto disease can cause scarring alopecia and should be considered in diagnosis.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.